Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 8/20 | 0.77 |
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.48 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30885529 | 0.87 | BCL2L1 (1.00) | BCL2L1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL14808194 | 0.75 | CNR1 (1.00) | BCL2L1CNR1ALDH1A1NPC1RAB9A | |
| SCHEMBL2625445 | 0.72 | BCL2L1 (0.60) | BCL2L1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL23607124 | 0.72 | CNR1 (0.71) | CNR1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11950436 | 0.72 | MGAM (0.54) | BCL2L1CNR1ALDH1A1RAB9AKDM4E | |
| SCHEMBL30037193 | 0.72 | NPC1 (0.70) | CNR1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL12768123 | 0.72 | NPC1 (0.70) | CNR1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4916595 | 0.71 | ALDH1A1 (1.00) | CNR1ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29074213 | 0.71 | NPC1 (0.62) | CNR1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL30608755 | 0.71 | NPC1 (0.62) | CNR1NPC1RAB9ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263491-A1 | ANTI-EGFR ANTIBODY DRUG CONJUGATES | ABBVIE INC (US) | 2025-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263491-A1 | ANTI-EGFR ANTIBODY DRUG CONJUGATES | EGFR, ERBB2, ERBB3 | BCL2L1 31/4885CNR1 2215/4885ALDH1A1 1891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.